Paul de Boissieu

Temozolomide Alone or Combined with Capecitabine for the Treatment of Advanced Pancreatic Neuroendocrine Tumor

Louis de Mestier, Thomas Walter, Camille Evrard et al. · Neuroendocrinology · 2019 · 58 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Comparison of Temozolomide-Capecitabine to 5-Fluorouracile-Dacarbazine in 247 Patients with Advanced Digestive Neuroendocrine Tumors Using Propensity Score Analyses

Louis de Mestier, Thomas Walter, Hédia Brixi et al. · Neuroendocrinology · 2019 · 50 citations

Medicine, Oncology, Pharmacotherapy +16

Classic Metaphyseal Lesions among Victims of Abuse

C. Adamsbaum, Paul de Boissieu, Jean Paul Teglas et al. · The Journal of Pediatrics · 2019 · 49 citations

Medicine, Pathology, Trauma-related Disorders +9

Notoriety bias in a database of spontaneous reports: the example of osteonecrosis of the jaw under bisphosphonate therapy in the French national pharmacovigilance database

Paul de Boissieu, Lukshe Kanagaratnam, Malak Abou Taam et al. · Pharmacoepidemiology and Drug Safety · 2014 · 43 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Absorbable Polyglactin vs. Non-Cross-linked Porcine Biological Mesh for the Surgical Treatment of Infected Incisional Hernia

Yohann Renard, Louis de Mestier, Julie Henriques et al. · Journal of Gastrointestinal Surgery · 2019 · 26 citations

Medicine, Surgery, General Surgery +12